Detalhe da pesquisa
1.
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
JAMA
; 325(11): 1074-1087, 2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625505
2.
Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.
J Pediatric Infect Dis Soc
; 13(3): 159-185, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339996
3.
Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents.
J Pediatric Infect Dis Soc
; 11(5): 177-185, 2022 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107571
4.
Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents.
J Am Heart Assoc
; 11(20): e025915, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250670
5.
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents.
EClinicalMedicine
; 40: 101112, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485878
6.
Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents.
J Pediatric Infect Dis Soc
; 10(5): 629-634, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388760